Our NAV estimate is the result of applying a forward cap rate to annualized NOI. Our $41 target price represents a ~22x multiple on 2025E earnings and an ~5% cap rate on forward NOI. We believe this valuation is reasonable given AMH’s consistently strong earnings growth profile, which will likely accelerate next year.
|